Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sordina IORT Technologies is an Italian medical technology company focused on radiation oncology devices rather than therapeutics. The company designs, manufactures, distributes, and services miniaturized mobile electron linear accelerators used for Intra Operative electron Radiation Therapy (IOeRT) and for FLASH radiotherapy research and emerging clinical applications. Its core product portfolio includes the LIAC HWL IOeRT system, NOVAC 11 mobile IOeRT accelerator, ElectronFlash preclinical FLASH research accelerator, and the Chc FlashPrime FLASH medical device platform. The company also offers related accessories, treatment-planning capabilities, and technical support for hospitals and research centers. Sordina is active internationally and positions itself as a specialized oncology device developer supporting both established intraoperative radiotherapy workflows and next-generation FLASH radiation therapy development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sordina IORT Technologies.